BCL2L1 and neoplasm: To examine if the expression of cadherin 1 was altered in the tumor cells infected with RCASBP-Bcl-xL, we measured cadherin 1 levels by Western blot analysis using an anti–cadherin 1 antibody (clone 36) (Figure 8E).